Curis | CRIS - Trade Debtors


Curis reported $2.55M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Alaunos Therapeutics USD 2K 0 Jun/2025
Amgen USD 9.14B 432M Mar/2026
AstraZeneca USD 17.88B 1.17B Mar/2026
Bayer EUR 18.55B 4.36B Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
CSL USD 4.32B 1.35B Dec/2025
Curis USD 2.55M 400K Jun/2024
Eli Lilly USD 21.18B 1.02B Mar/2026
Exelixis USD 328.95M 42.03M Mar/2026
Gilead Sciences USD 4.74B 172M Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Incyte USD 1.05B 27.09M Mar/2026
Merck USD 11.78B 345M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 482M 85M Mar/2026
Takeda JPY 876.35B 118.43B Mar/2026
TG Therapeutics USD 392.05M 86.42M Mar/2026
Verastem USD 9.01M 8.81M Dec/2025
Xoma USD 14.78M 4.96M Jun/2024